Mursla Bio announces promising results for EvoLiver test in liver cancer detection
Mursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to significantly improve cancer outcomes for at-risk patients...
cancer
Boston Scientific to buy Intera Oncology, maker of liver cancer treatment
Dive Brief: Boston Scientific said Monday it has agreed to acquire Intera Oncology, which makes treatments for liver tumors primarily...
Liver cancer stem cells shown to use immune system as shield to spark disease recurrence | News Center
Liver cancer cells that rub shoulders with a class of immune cells called macrophages promote treatment-resistant recurrence of the cancer,...
Deep learning for oncologic treatment outcomes and endpoints evaluation from CT scans in liver cancer
Cohorts construction and ethicsCohort A has the official title of “RATIONALE-208: A Phase 2, Open-label, Multicenter Study to Investigate the...
Finding The Right Treatment For Liver Cancer: Expert Explains The Shift to Personalised Medicine
Liver cancer often goes unnoticed in its early stages, as its symptoms can be subtle or mistaken for other less...
‘Early treatment of hepatitis B is key to preventing liver cancer and reducing healthcare costs’ < Hospital < Article
Hepatitis B is caused by the hepatitis B virus (HBV), a leading cause of chronic liver disease and...
